Description
Vascular Disruptive Agents for the Treatment of Cancer, 2010
Coordinator: Meyer Tim
Language: EnglishSubjects for Vascular Disruptive Agents for the Treatment of Cancer:
Publication date: 11-2014
256 p. · 15.5x23.5 cm · Paperback
Publication date: 09-2010
256 p. · 15.5x23.5 cm · Hardback
Description
/li>Contents
/li>Biography
/li>Comment
/li>
This book discusses preclinical target identification and validation, and the optimum pre-clinical animal models
Biomarkers and imaging modalities used to assess the efficacy of these agents are examined
A review of the clinical development of key drugs is provided
Recent research exploring rational combinations of VDAs with other agents is reviewed and the potential place of VDAs in the future of cancer therapy is critically appraised
Includes supplementary material: sn.pub/extras